Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRSF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CASKIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLPTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NXF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00470 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR6840 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QRICH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARFIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKTIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRAID - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on